PALI$1.228.93%0.10
Palisade Bio Inc (PALI)
Date: 2026-11-03 16:00O: 1.14H: 1.23L: 1.13C: 1.22Vol: 788.3k
Palisade Bio Inc stock is traded at $1.22, with a volume of 792,287. It is up +8.93% in the last 24 hours and down -15.28% over the past month. Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Previous Close:
$1.12
Open:
$1.14
24h Volume:
792,287
Relative Volume:
0.20
Market Cap:
$212.61M
Revenue:
$250.00K
Net Income/Loss:
-$24.15M
P/E Ratio:
-
EPS:
-$1.07
Net Cash Flow:
-$12.40M
1W Performance:
+1.67%
1M Performance:
-15.28%
6M Performance:
-38.69%
1Y Performance:
-39.00%
1-Day Range:
$1.13$1.23
1-Week Range:
$1.08$1.25
52-Week Range:
$1.08$2.86
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 704-4900Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Palisade Bio Inc Stock (PALI) Upgrades & Downgrades
Palisade Bio Inc Stock (PALI) Financials Data
Palisade Bio Inc Stock (PALI) Insider Trading
- Williams Donald AllenOct 02 '26Director
- Transaction
- Buy
- Cost
- $1.46
- #Shares
- 10,000
- Value ($)
- 14,600
- #Shares Total
- 1,590,294
- Williams Donald AllenOct 01 '26Director
- Transaction
- Buy
- Cost
- $1.42
- #Shares
- 10,000
- Value ($)
- 14,200
- #Shares Total
- 1,580,294
- Baltera Robert Jr.Jul 09 '26Director
- Transaction
- Buy
- Cost
- $1.96
- #Shares
- 25,000
- Value ($)
- 48,900
- #Shares Total
- 461,904
- Baltera Robert Jr.Jul 08 '26Director
- Transaction
- Buy
- Cost
- $1.99
- #Shares
- 20,000
- Value ($)
- 39,798
- #Shares Total
- 436,904
- Finley John DavidJul 07 '26Officer
- Transaction
- Proposed Sale
- Cost
- $2.07
- #Shares
- 146,798
- Value ($)
- 303,343
- #Shares Total
- 0
- Jones Mitchell LawrenceJul 07 '26Chief Medical Officer
- Transaction
- Sale
- Cost
- $2.05
- #Shares
- 51,880
- Value ($)
- 106,536
- #Shares Total
- 94,009
- Finley John DavidJul 07 '26CEO, CFO
- Transaction
- Option Exercise
- Cost
- $0.7
- #Shares
- 133
- Value ($)
- 93
- #Shares Total
- 217,688
- Finley John DavidJul 07 '26CEO, CFO
- Transaction
- Sale
- Cost
- $2.07
- #Shares
- 146,798
- Value ($)
- 303,343
- #Shares Total
- 217,555
- Jones Mitchell LawrenceJul 07 '26Officer
- Transaction
- Proposed Sale
- Cost
- $2.04
- #Shares
- 53,000
- Value ($)
- 108,120
- #Shares Total
- 0
- Baltera Robert Jr.Jul 07 '26Director
- Transaction
- Buy
- Cost
- $2.03
- #Shares
- 30,000
- Value ($)
- 61,044
- #Shares Total
- 416,904
